In DepthInfectious Disease

Scandal clouds China's global vaccine ambitions

See allHide authors and affiliations

Science  29 Apr 2016:
Vol. 352, Issue 6285, pp. 506
DOI: 10.1126/science.352.6285.506

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Health experts hail two new Chinese-made vaccines against hand, foot, and mouth disease as a milestone against a malady that has run rampant in China. But that triumph was overshadowed by a safety crisis involving other homegrown vaccines. In recent weeks, police have arrested more than 200 people in connection with the nationwide distribution of 2 million doses of expired Chinese-made vaccines against scourges such as hepatitis B and rabies. No adverse reactions have been confirmed. China's vaccine developers hope the debacle won't derail efforts to make inroads into the global $33 billion vaccine market. But without a major overhaul, China's vaccine system might not recover quickly.

  • * in Beijing